What did @fitmakayla actually say?
She didn't make clinical claims. She made a sourcing pitch. The video is essentially a funnel: comment "info," get a DM, presumably get a referral link or affiliate code to an unregulated peptide vendor. She frames it as helpfulness, saying she found her source through "trial and error" and that it's "third party tested" with posted purity results. That's the whole argument. No efficacy claims, no dosing advice, just a trust signal built around vendor vetting credentials she can't actually verify for you.
To her credit, she acknowledged that the space has "a lot of scams" and "spun companies," which is accurate. But the solution she offers, a DM with a vendor link, doesn't solve that problem. It replaces one unverified source with another unverified source, except this one comes with a social media personality attached.
Does the science back this up?
There's no science to evaluate here, because she made no scientific claims. That's actually worth flagging. Retatrutide (LY3437943), the compound she appears to be referencing, is a triple GIP/GLP-1/glucagon receptor agonist developed by Eli Lilly. It's in Phase 3 trials as of 2024. It is not FDA-approved. It is not commercially available through any legitimate channel.
A 2023 Phase 2 trial published in The New England Journal of Medicine (Jastreboff et al., 2023) showed retatrutide produced up to 24.2% body weight reduction over 48 weeks in adults with obesity. Those results are real and notable. But that trial used pharmaceutical-grade retatrutide manufactured under strict controls, administered by clinicians, with safety monitoring. Whatever a TikTok DM vendor is selling under that name is not that product. There is no regulatory pathway for a consumer to legally obtain retatrutide right now, period.
What did they get wrong (or right)?
She got one thing right: the gray-market peptide space is full of scams and low-quality products. A 2022 analysis by Valisure found significant quality and potency inconsistencies across compounded and gray-market peptide products. The problem of "spun companies" and mislabeled compounds is documented and real.
What she got wrong is the implied solution. "Third party tested" sounds rigorous, but in the unregulated research chemical market, third-party certificates of analysis are frequently incomplete, outdated, or issued by labs with no accreditation. A COA confirming peptide identity doesn't tell you about bacterial endotoxins, residual solvents, or sterility, all of which matter if someone is injecting this. She also sidesteps the legal reality entirely. Selling retatrutide to consumers in the U.S. without a prescription and without FDA approval is not a gray area. It's a federal legal exposure for the vendor and a health risk for the buyer. Framing this as a helpful community resource obscures that entirely.
What should you actually know?
If you're interested in GLP-1 class medications, there are legal, medically supervised options available through licensed telehealth platforms. FDA-approved semaglutide and tirzepatide are prescribed by licensed clinicians, dispensed by licensed pharmacies, and come with actual safety oversight. Compounded semaglutide from 503A and 503B pharmacies operates in a specific regulatory framework that has nothing to do with a vendor someone found through TikTok DMs.
Retatrutide specifically doesn't exist in any legitimate consumer channel yet. If someone is selling it, they're selling a research chemical of unknown purity and origin, manufactured outside pharmaceutical standards, with no clinical oversight. The Jastreboff et al. Phase 2 data is genuinely exciting science. But excitement about a drug's trial results is not a reason to inject something sourced from an anonymous vendor a fitness influencer DMed you about.
For any peptide therapy, the relevant questions are: Is the prescriber licensed? Is the pharmacy licensed and inspectable? Is there a real diagnosis and monitoring plan? A TikTok DM answers none of those questions.